Shilpa Viswanathan

Director, Real-World Evidence Oncology
Gilead Sciences, Inc.

Poster(s):

• (B-230) Optimizing the Identification and Classification of Non-Small Cell Lung Cancer (NSCLC): Validation and Implementation of a Patient Cohort Algorithm in Claims Databases
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET